PharmaBlock picks Dr Zhengtian Gu as Sr VP of Quality & Regulatory Affairs

PharmaBlock, based in China, has announced the appointment of Dr Zhengtian Gu as Senior Vice President (VP) of Quality and Regulatory Affairs, responsible for corporate quality management and regulatory affairs. Dr Gu has more than 20 years of R&D and management experience in pharmaceutical development. He has worked at Proctor & Gamble, GSK, 3M, and Theravance Biopharma in the fields of analytical chemistry and drug metabolism and pharmacokinetics. Prior to joining PharmaBlock, Dr Gu served as Vice President of Analytical Development & Quality Control at Theravance, spearheading critical efforts for new drug development and management. He led the CMC team for the Vibativ (Telavancin for injection) project from Phase II to regulatory approval and commercialization in US, EU, Canada, Russia and other countries. Since 1998, Dr Gu has participated in or led over ten new drug development projects, with five of them achieved market approval.